SEPTO-OPTIC DYSPLASIA

Clinical trials for SEPTO-OPTIC DYSPLASIA explained in plain language.

Never miss a new study

Get alerted when new SEPTO-OPTIC DYSPLASIA trials appear

Sign up with your email to follow new studies for SEPTO-OPTIC DYSPLASIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Daily injection trial aims to curb uncontrollable hunger in rare brain disorder

Disease control Recruiting now

This study is testing whether a daily injection called setmelanotide can help people aged 4 and older with a rare form of obesity caused by brain injury (hypothalamic obesity). Participants will receive either the real drug or a placebo for 26 weeks to see if it safely reduces bo…

Matched conditions: SEPTO-OPTIC DYSPLASIA

Phase: PHASE3 • Sponsor: Rhythm Pharmaceuticals, Inc. • Aim: Disease control

Last updated Mar 25, 2026 14:07 UTC

SEPTO-OPTIC DYSPLASIA

Get alerted when new SEPTO-OPTIC DYSPLASIA trials appear

Daily injection trial aims to curb uncontrollable hunger in rare brain disorder